its gone as have the buyers. well done management. they've missed on timelines ,and capital & operating costs have increased
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025